PDF
Published
2021-06-04
Issue
Section
Editor's Choice
License
Copyright (c) 2021 Asha Elgonda
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in the Public Health Review are distributed with a Creative Commons Noncommercial Attribution license (CC BY-NC 4.0). This means that each author holds the copyright to their work, and grants users the rights to: share (copy and/or redistribute the material in any medium or format) or adapt (remix, transform, and/or build upon the material) the article, as long as the original author and source are cited, and the use is for noncommercial purposes. Permission is not needed for these noncommercial uses. Read the summary terms, or the full legal license code.
Candida auris
An Emerging Antibiotic-Resistant Threat
Asha Elgonda
Graduate Student
Abstract
- Candida auris is a fungal pathogen that can cause serious infection in humans.
- According to the Centers for Disease Control and Prevention (CDC), C. auris is an emerging global health threat and has been isolated in over 40 countries.
- Clinical signs of C. auris infections include bloodstream infections, myocarditis, urinary tract infection, surgical wound infections, and skin abscesses.
- Microbiologists hypothesize C. auris may be multidrug-resistant due to its biofilm formation.
- Hospitalized ICU patients have a higher risk of contracting C. auris infection, which is especially seen with the current COVID-19 pandemic.
- The Minnesota Department of Health (MDH) and CDC are conducting surveillance of C. auris in hopes of preventing future outbreaks.
